Manufacturer record
Zee Laboratories 47: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Zee Laboratories 47 (Himachal Pradesh) were declared Not of Standard Quality between October 2025 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Zee Laboratories 47 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amlodipine Tablets I.P. 2.5 mg | 424-1522Mfg 2024-08 · Exp 2026-07 | The sample is not of standard quality for The reason stated under Description of The tablets.Description | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Glimepiride, Pioglitazone & Metformin (Extended Release) Tablets (AXYLIM-PM 1 Tablets) | 424-73Mfg 2024-01 · Exp 2026-06 | The sample does not conform to claim as per Manufacturer Specification with respect to the test for "Assay" of Pioglitazone Hydrochloride equivalent to Pioglitazone.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.